BioSig Technologies: ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib

Press/Media: Expert Comment

PeriodMay 20 2020

Media coverage

1

Media coverage

  • TitleBioSig Technologies: ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib
    Media name/outletIndia Pharma News
    CountryIndia
    Date5/20/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang